StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

Vycor Medical gross margin

Gross margin is gross profit as a percentage of revenue.

Vycor Medical's gross margin for the twelve months ending Jun 30, 2026 was 83.4%. For fiscal 2025 it was 83.8%, against 89.5% the year before. The highest annual figure on record is 90.3% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202583.8%−5.7
FY2024Dec 31, 202489.5%−0.6
FY2023Dec 31, 202390.1%+1.6
FY2022Dec 31, 202288.5%−1.8
FY2021Dec 31, 202190.3%+1.9
FY2020Dec 31, 202088.4%−1.9
FY2019Dec 31, 201990.3%+1.6
FY2018Dec 31, 201888.8%+5.2
FY2017Dec 31, 201783.6%−3.7
FY2016Dec 31, 201687.3%+1.7
FY2015Dec 31, 201585.6%−1.9
FY2014Dec 31, 201487.5%+1.6
FY2013Dec 31, 201385.9%+0.8
FY2012Dec 31, 201285.1%+3.2
FY2011Dec 31, 201181.9%−2.7
FY2010Dec 31, 201084.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202682.4%−1.3
Q1 FY2026Mar 31, 202681.8%−0.3
Q4 FY2025Dec 31, 202580.4%−6.8
Q3 FY2025Sep 30, 202588.0%−2.6
Q2 FY2025Jun 30, 202583.7%−7.7
Q1 FY2025Mar 31, 202582.2%−6.9
Q4 FY2024Dec 31, 202487.3%+0.9
Q3 FY2024Sep 30, 202490.6%+1.1
Q2 FY2024Jun 30, 202491.3%−0.4
Q1 FY2024Mar 31, 202489.0%−2.5
Q4 FY2023Dec 31, 202386.4%+0.1
Q3 FY2023Sep 30, 202389.5%+3.1
Q2 FY2023Jun 30, 202391.8%+0.3
Q1 FY2023Mar 31, 202391.5%+2.1
Q4 FY2022Dec 31, 202286.3%−2.1
Q3 FY2022Sep 30, 202286.4%−3.0
Q2 FY2022Jun 30, 202291.5%−0.5
Q1 FY2022Mar 31, 202289.4%−1.0
Q4 FY2021Dec 31, 202188.4%+0.1
Q3 FY2021Sep 30, 202189.4%+4.1
Q2 FY2021Jun 30, 202192.0%+0.4
Q1 FY2021Mar 31, 202190.4%+1.7
Q4 FY2020Dec 31, 202088.3%−0.4
Q3 FY2020Sep 30, 202085.3%−5.7
Q2 FY2020Jun 30, 202091.6%+0.4
Q1 FY2020Mar 31, 202088.7%−1.0
Q4 FY2019Dec 31, 201988.7%−0.4
Q3 FY2019Sep 30, 201991.0%+1.3
Q2 FY2019Jun 30, 201991.2%+6.8
Q1 FY2019Mar 31, 201989.7%−1.3
Q4 FY2018Dec 31, 201889.1%+20.4
Q3 FY2018Sep 30, 201889.7%+4.3
Q2 FY2018Jun 30, 201884.4%−2.8
Q1 FY2018Mar 31, 201891.0%+2.2
Q4 FY2017Dec 31, 201768.7%−22.1
Q3 FY2017Sep 30, 201785.4%−3.1
Q2 FY2017Jun 30, 201787.2%–
Q1 FY2017Mar 31, 201788.8%–
Q4 FY2016Dec 31, 201690.8%–
Q3 FY2016Sep 30, 201688.5%–

More Vycor Medical figures

See a number that looks wrong?